Suchergebnisse - "Abdallah, Mahmoud S"

PubPharm (27)

11

Chronotherapeutic neuroprotective effect of verapamil against lipopolysaccharide-induced neuroinflammation in mice through modulation of calcium-dependent genes

enthalten in: Molecular medicine | 2022

von Mosalam, E. | Elberri, A. | Sallam, A. | +5

12

Chronotherapeutic neuroprotective effect of verapamil against lipopolysaccharide-induced neuroinflammation in mice through modulation of calcium-dependent genes

enthalten in: Molecular medicine | 2022

von Mosalam, E. | Elberri, A. | Sallam, A. | +5

13

Ivermectin role in COVID-19 treatment (IRICT) : single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial

enthalten in: Expert review of anti-infective therapy | 2022

von Elshafie, A. | Elsawah, H. | Hammad, M. | +6

14

Retraction Note : The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2022

von Abdallah, M. | Mosalam, E. | Zidan, A. | +4

RetractionOf: Neurotherapeutics. 2020 Oct;17(4):1897-1906. - PMID 32500486

15

The clinicopathological and prognostic factors of hepatocellular carcinoma : a 10-year tertiary center experience in Egypt

enthalten in: World journal of surgical oncology | 2022

von Sweed, D. | Sweed, E. | Moaz, I. | +11

16

The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt

enthalten in: World journal of surgical oncology | 2022

von Sweed, D. | Sweed, E. | Moaz, I. | +11

17

The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt

enthalten in: World journal of surgical oncology | 2022

von Sweed, D. | Sweed, E. | Moaz, I. | +11

18

Retraction Note: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

enthalten in: Neurotherapeutics | 2022

von Abdallah, M. | Mosalam, E. | Zidan, A. | +4

19

Retraction Note: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

enthalten in: Neurotherapeutics | 2022

von Abdallah, M. | Mosalam, E. | Zidan, A. | +4

20

Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder

enthalten in: CNS neuroscience & therapeutics | 2021

von Abdallah, M. | Ramadan, A. | Omara-Reda, H. | +6

RetractionIn: CNS Neurosci Ther. 2024 Mar;30(3):e14667. - PMID 38465461